Navigation Links
Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
Date:10/28/2009

de, but are not limited to, references to Anadys' strategy, development programs, and ability to develop novel medicines for the treatment of hepatitis C. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. For example, the results of preclinical and early clinical studies may not be predictive of future results, and Anadys cannot provide any assurances that ANA598 or ANA773 will not have unforeseen safety issues, will have favorable results in ongoing or future clinical trials or will receive regulatory approval. Risk factors that may cause actual results to differ are more fully discussed in Anadys' SEC filings, including Anadys' Form 10-K for the year ended December 31, 2008 and Anadys' Form 10-Q for the quarter ended June 30, 2009. All forward-looking statements are qualified in their entirety by this cautionary statement. Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

SOURCE Anadys Pharmaceuticals, Inc.


'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
6. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
7. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
8. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... Aug. 1, 2014 Research and ... "Global Medical Biosensors Market 2014-2018" report ... http://photos.prnewswire.com/prnh/20130307/600769 Medical biosensors are used ... physicochemical detectors. These biosensors monitor health status, disease ... non-invasive methods. They are cost-effective and user-friendly devices. ...
(Date:8/1/2014)... and PALO ALTO, Calif. , Aug. ... Inc. (CFRI) today announced a partnership to expand awareness ... community through the CFChef Shares program. CFChef Shares will ... part of AbbVie,s CFChef program – an online resource ... to maintain a healthy diet by submitting recipes to ...
(Date:8/1/2014)... DALLAS , August 1, 2014 ... Care Market by Type (Traditional Wound Closure, Anti infective), ... Active (Artificial Skin & Skin Substitutes), Pressure Relief ... by MarketsandMarkets, the global Wound Care Market is expected ... Billion in 2014, growing at a CAGR of ...
Breaking Medicine Technology:Global Medical Biosensors Market 2014-2018: Key Vendors are Abbott, Bayer, LifeScan and F. Hoffmann-La Roche 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 3Wound Care Market Worth $18.3 Billion by 2019 2Wound Care Market Worth $18.3 Billion by 2019 3
(Date:8/1/2014)... By Steven Reinberg ... -- Stress at work may raise your risk of heart ... industry or have a blue-collar job, U.S. health officials reported ... they added. "Workplace factors that increase risk include job ... smoke -- and noise," explained lead researcher Dr. Sara Luckhaupt, ...
(Date:8/1/2014)... PROVIDENCE, R.I. [Brown University] New research shows that ... member was incarcerated have a 16-percent greater risk of ... have a family member sent to prison. The finding, ... that the nation,s high rate of imprisonment may be ... some families. , "These people were children when this ...
(Date:8/1/2014)... 2014 Today marks the official ... the convergence of three well respected market leaders ... UT; Premier Imaging Financial Services (PIFS) of Columbus, ... NC. Together these organizations serviced, and will continue ... group practices, including Charlotte Radiology (Charlotte, NC) and ...
(Date:8/1/2014)... WA (PRWEB) August 01, 2014 “When ... problem throughout your entire home.“ In a newly released ... or Attic Insulation Needs To Be Replaced ,” Clean ... deteriorated, become damp, or been infested by critters. ... cleaning quote from Clean Crawls - http://www.cleancrawl.com/contact . ...
(Date:8/1/2014)... According to the Get Rid ... by Vkool.com, this is a comprehensive guide that ... cold sores including:,     Swollen ... sore throat and fever ,     Headache and ... are uncomfortable ,     Drooling in small children ...
Breaking Medicine News(10 mins):Health News:Some Jobs Harder on the Heart Than Others, Report Finds 2Health News:Jailed family member increases risks for kids' adult health 2Health News:Jailed family member increases risks for kids' adult health 3Health News:Three Market Leaders Come Together As One To Form A New Breed of Medical Billing Companies 2Health News:Three Market Leaders Come Together As One To Form A New Breed of Medical Billing Companies 3Health News:5 Signs That Insulation Should Be Replaced Detailed in a Newly Released Article By Clean Crawls 2Health News:Get Rid Of Cold Sores Fast Book Review Exposes Ellie Gadsby's Guide For Treating Fever Blisters – Vkool.com 2Health News:Get Rid Of Cold Sores Fast Book Review Exposes Ellie Gadsby's Guide For Treating Fever Blisters – Vkool.com 3
... Harris ... , ... 2009 -- Harris Williams & Co. is pleased to announce that Verathon Inc., a portfolio ... buyer Roper Industries (NYSE: ROP). Harris Williams & Co. acted as the exclusive advisor ...
... , HOLMDEL, ... Sparta Systems, Inc., the maker of TrackWise (®) software ... solutions, is pleased to announce new additions to the TrackWise ... Medical Device Vigilance reporting. The addition of ClinicalTrials.gov reporting ...
... , , , ... Quality Alliance (MTQUA, http://www.mtqua.org ), announces the first ... medical travel providers worldwide. , "All medical tourists who want ... medical travel with a Certified International Patient Advisor (CIPA) and ...
... 2010 AIUM Annual Convention and Preconvention Program, the only ... all disciplines of medical ultrasound, to be held March ... Convention focuses on emerging applications and unique opportunities for ... continues to advance and expand into new arenas. ...
... not being vaccinated against the seasonal flu any more often ... the importance of influenza vaccines resulting from the worldwide outbreak ... study. As of the middle of November, about 32 ... recommended to receive a flu vaccination had been inoculated against ...
... Finding is good news for first-line treatment in Africa, researchers ... finding that has implications for how the AIDS virus is ... be given without routine monitoring by lab tests. , But ... to monitor the progression of the disease and guide the ...
Cached Medicine News:Health News:Harris Williams & Co. Advises Verathon Inc. in its Sale to Strategic Buyer Roper Industries 2Health News:Harris Williams & Co. Advises Verathon Inc. in its Sale to Strategic Buyer Roper Industries 3Health News:TrackWise(R) Electronic Regulatory Reporting Solution Enables Companies to Meet Current and Future Mandates 2Health News:TrackWise(R) Electronic Regulatory Reporting Solution Enables Companies to Meet Current and Future Mandates 3Health News:Medical Travel Quality Alliance to Certify Medical Tourism Agents for Safer, Quality Health Care for Traveling International Patients 2Health News:AIUM gears up for 2010 Annual Convention in San Diego, Calif. 2Health News:American adults receiving flu vaccine at about the same rate as in 2008, study finds 2Health News:American adults receiving flu vaccine at about the same rate as in 2008, study finds 3
For the quantitative determination of Alanine Aminotransferase in serum. Optimized IFCC without P-5'-P, Linearity: 500 IU/L at 37 C. Liquid Working Reagent prepared with simple 1:9 dilution....
Intended for the quantitative determination of total protein in serum. Reaction: endpoint. Wavelength: 540 nm. Linearity: 12 g/dL (120 g/L). Ready to use liquid reagent....
Urea nitrogen (BUN) liquid reagent is used for the kinetic quantitative determination of Urea Nitrogen (BUN) in human serum used in routine examination and monitoring of therapy and relapses....
For the direct colorimetric determination of Urea Nitrogen (BUN) in human serum or plasma....
Medicine Products: